Michael D. Powers - Concepedia

Author

Michael D. Powers

Also Known As

Lawrence H. Moulton, M D Powers, M. Powers, M.D. Powers, MICHAEL D. POWERS, Michael D. Powers, Michael Powers, Powers, Michael

492

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Utah Veterans Health Administration Brigham and Women's Hospital Harvard University

About

Michael D. Powers is an author at University of Minnesota specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.9K
2	Health Sciences	4	4	148
3	Social Sciences	2	2	41
4	Education	1	1	47
5	Behavioral Sciences	1	1	30

Michael D. Powers

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension Richard P. Lifton, Robert G. Dluhy, Michael D. Powers, Nature HypertensionMedicinePhysiologyPrimary AldosteronismGlucocorticoid-remediable Aldosteronism	1992	1.2K
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase Richard P. Lifton, Robert G. Dluhy, Michael D. Powers, Nature Genetics HypertensionGeneticsPhysiologyChimaeric Gene DuplicationsPrimary Aldosteronism	1992	336
Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Wade S. Samowitz, Michael D. Powers, Lisa Spirio, PubMed Gastrointestinal OncologyMedicinePathologyColorectal CancerLarger Adenomas	1999	223
<i>N</i> -naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromers Ajay Yekkirala, Mary M. Lunzer, Christopher R. McCurdy, Proceedings of the National Academy of Sciences μ/κ-Opioid HeteromersPain MedicinePlace PreferenceMolecular PainPharmacotherapy	2011	67
Two contemporaneous mitogenomes from terminal Pleistocene burials in eastern Beringia Justin Tackney, Ben A. Potter, Jennifer Raff, Proceedings of the National Academy of Sciences	2015	60
Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK<sub>2</sub>) Receptors by Novel Bivalent Ligands Yaguo Zheng, Eyup Akgün, Kaleeckal G. Harikumar, Journal of Medicinal Chemistry	2008	58
Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR<sub>5</sub>) Eyup Akgün, Muhammad I. Javed, Mary M. Lunzer, Journal of Medicinal Chemistry	2015	58
Early intervention for children with autism. Michael D. Powers Early Childhood DevelopmentPediatricsEducationAutismPreschool Development	1992	47
Non-trophic interactions in deserts: Facilitation, interference, and an endangered lizard species Alessandro Filazzola, Michael Westphal, Michael D. Powers, Basic and Applied Ecology Trophic ImpactSpecie InteractionEcosystem InteractionEcological ProcessLizard Species	2017	45
Putative Kappa Opioid Heteromers As Targets for Developing Analgesics Free of Adverse Effects Morgan Le Naour, Mary M. Lunzer, Michael D. Powers, Journal of Medicinal Chemistry Pain MedicineMolecular PainPharmacotherapyExperimental PharmacologyAnalgesics Free	2014	35

Page 1